C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/4965 (2006.01) A61K 31/497 (2006.01) C07D 241/10 (2006.01) C07D 401/10 (2006.01) C07D 403/10 (2006.01)
Patent
CA 2481229
The present invention is directed to compounds comprising a 2,3- diphenylpyrazine moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention. An example of a suitable compound includes a compound of Formula A: (see formula A)
La présente invention concerne des composés comprenant un groupe fonctionnel 2,3-diphénylpyrazine inhibant l'activité de Akt, une protéine kinase serine/thréonine. L'invention concerne également des compositions chimiothérapeutiques contenant ces composés. L'invention concerne également des méthodes permettant de traiter le cancer par administration des composés susmentionnés.
Duggan Mark E.
Lindsley Craig W.
Zhao Zhijian
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Substituted pyrazine inhibitors of akt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazine inhibitors of akt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazine inhibitors of akt will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1548641